All GLP-1 and GIP/GLP-1 medications for weight management carry a boxed warning about the risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Telehealth platforms like Doctronic.ai offer convenient access to medical professionals who can provide guidance and treatment options anytime, anywhere
What makes these numbers particularly significant is the consistency across the trial population
A Health Canada-approved prescription pathway protects you, ensures the right starting dose, and supports you through the gradual dose escalation process
it works best as an adjunct alongside a calorie deficit and activity
AOD 9604 works without affecting your hormone levels, making it a safe option even when hormones are out of sync